BBLG
Bone Biologics Corp (BBLG)
$
06About Bone Biologics Corp (BBLG)
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Details
Daily high
$1.10
Daily low
$1.02
Price at open
$1.10
52 Week High
$4.74
52 Week Low
$0.80
Market cap
566,300
Dividend yield
0.00%
Volume
281,104
Avg. volume
166,008
P/E ratio
-.20
Bone Biologics Corp News
Details
Daily high
$1.10
Daily low
$1.02
Price at open
$1.10
52 Week High
$4.74
52 Week Low
$0.80
Market cap
566,300
Dividend yield
0.00%
Volume
281,104
Avg. volume
166,008
P/E ratio
-.20